Compugen Ltd. CGEN
$ 1.41
-2.08%
Annual report 2023
added 11-09-2024
Country |
Israel |
IPO year |
2000 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBALSPB |
CEO |
Dr. Anat Cohen-Dayag |
Employees in the company |
61 |
Shares |
87.6 M |
Market Cap[1] |
$ 124 M |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
8.93 |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.